New blood test may spot silica lung damage before symptoms appear

NCT ID NCT07376291

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a specific antibody in the blood, called anti-CD146, can help doctors diagnose lung diseases caused by breathing in silica dust at work. Silica exposure can lead to serious lung problems like scarring, inflammation, and cancer, but there is currently no simple blood test to catch these diseases early. Researchers will compare 110 people with and without silica exposure to see if the antibody levels differ and relate to lung health.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Anti-CD146 autoantibodies (AACD146) as a blood biomarker

What this could lead to

If successful, this could lead to a simple blood test for early detection of silica-related lung diseases, allowing earlier treatment.

What could go wrong

This is an early-stage diagnostic study, not a treatment trial. The biomarker may not prove accurate enough for clinical use, and results may not apply to all exposed workers.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EXPOSURE OCCUPATIONAL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lung disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.